本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ocular Therapeutix

11.03
-0.0500-0.45%
盘后11.030.00000.00%19:38 EDT
成交量:213.25万
成交额:2,373.96万
市值:17.57亿
市盈率:-9.59
高:11.31
开:10.85
低:10.76
收:11.08
数据加载中...
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities